CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 237 filers reported holding CLOVIS ONCOLOGY INC in Q1 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,117,000 | -10.3% | 40,100 | +15.6% | 0.27% | -13.8% |
| Q4 2017 | $2,360,000 | -2.6% | 34,700 | +18.0% | 0.31% | +11.8% |
| Q3 2017 | $2,423,000 | +25.0% | 29,400 | +42.0% | 0.28% | +33.5% |
| Q2 2017 | $1,938,000 | +353.9% | 20,700 | +209.0% | 0.21% | +335.4% |
| Q1 2017 | $427,000 | – | 6,700 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |